| ID: | 136 | |
|---|---|---|
| Name: | Compound 136 | |
| Description: | Original numeration in publication: 6a | |
| Labels: | Training_set, Phthalazines | |
| CAS: | ||
| InChi Code: | InChI=1S/C28H21N5O/c34-28(33-29-19-20-9-3-1-4-10-20)22-15-17-23(18-16-22)30-27-25-14-8-7-13-24(25)26(31-32-27)21-11-5-2-6-12-21/h1-19H,(H,30,32)(H,33,34)/b29-19+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.15 |
El-Adl, K.; Ibrahim, M. K.; Khedr, F. a. A., H. S.; Eissa, I. H. Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2022, 355, e2100278. https://doi.org/10.1002/ardp.202100278 |
| 6.25541 |
Eq1: VEGFR-2 inhibition (Data used to train model) |